Labcorp Holdings Inc. (LH) Earnings Call Transcripts

Labcorp Holdings Inc.'s Latest Earnings Call - September 15, 2026

In the Q3 2026 earnings call for Labcorp Holdings Inc. (LH:US), management reaffirmed their revenue growth guidance of 5.4% to 6.3% for the year, alongside adjusted EPS growth expectations exceeding 11%. The company reported strong momentum entering the second half of the year, driven by specialty testing and a robust pipeline of acquisitions. Management highlighted a focus on margin expansion, targeting an increase of 75 to 150 basis points over the next three years, supported by operational efficiencies and technology investments.

Reported metrics

Guidance from management

Labcorp reaffirmed its 2026 guidance for revenue growth of 5.4% to 6.3% and adjusted EPS growth exceeding 11%. Management expressed confidence in achieving these targets and indicated strong momentum heading into the second half of the year.

What management said

Yes. So I'll give some back. I'll ask Julie to jump in with some specifics. But I'd say overall, we feel like the momentum that we've entered the second half and is very strong. As I look at the guidance we provided, obviously, there's just over 3 months left. I feel very strongly that reaffirming the guidance tells you we see a clear path forward to achieving the objectives that we've set forth for the rest of this ...

So they're all opportunities. It's interesting. Neurology is actually the smallest. But if you look at like Alzheimer's degrees, it's growing the Alzheimer's disease, it's growing the fastest. So we have a very broad portfolio of products for Alzheimer's disease. I think that, that's going to be a very important area for us as we move into the future. .

What analysts pressed on

Analysts raised concerns regarding the potential impact of PAMA on revenue and the overall utilization environment. There were questions about how the company plans to navigate legislative challenges and maintain growth amidst regulatory pressures.

Main topics on the call

• Revenue Growth Guidance — Labcorp reaffirmed its revenue growth guidance for 2026 at 5.4% to 6.3%, with adjusted EPS growth expected to exceed 11%. CEO Adam Schechter stated, "We feel very strongly that reaffirming the guidance tells you we see a...
• Margin Expansion Strategy — Management outlined a strategy for margin expansion, targeting 75 to 150 basis points over the next three years. CFO Julia Wang noted, "We expect both segments to be contributors like they have been in the last few years...
• Specialty Testing Growth — Specialty testing remains a key growth driver, with management noting that patients in specialty areas tend to receive 50% more tests per accession. Schechter highlighted that "the mix shift is helping with the test per ...
• Acquisition Pipeline — Labcorp's acquisition pipeline is described as strong, with management indicating that 1.5% to 2.5% of revenue growth is expected from acquisitions. Schechter mentioned, "The pipeline remains strong and stay tuned," sugg...

Read the full Labcorp Holdings Inc. transcript (September 15, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 58 Labcorp Holdings Inc. earnings call transcripts on record, spanning January 14, 2020 to September 15, 2026. Based on this history, Labcorp Holdings Inc. reports quarterly. The most recent call on file is dated September 15, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

LH

Exchange

NYSE

Country

US

Sector

Health Care

Industry

Health Care Providers and Services

Calls on record

58

First call

January 14, 2020

Most recent

September 15, 2026

Reporting cadence

quarterly